Back
Verrica Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
VRCA
Verrica Pharmaceuticals
Last Price:
1.22
Seasonality Move:
50.53%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- The current trend is relatively stagnant and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verrica Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Buy |
| 20-day SMA: | 1.01 | Buy |
| 50-day SMA: | 1.32 | Sell |
| 200-day SMA: | 4.97 | Sell |
| 8-day EMA: | 0.99 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 1.58 | Sell |
| 200-day EMA: | 3.93 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 48.94 | Sell |
| Chaikin Money Flow: | 737946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.44) | Sell |
| Bollinger Bands (100): | (0.62 - 5.5) | Sell |
Verrica Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 1.11 while VRCA 8-day simple moving average is 0.95, which is a Buy signal.
- The stock price of VRCA is 1.11 while Verrica Pharmaceuticals 20-day SMA is 1.01, which makes it a Buy.
- Verrica Pharmaceuticals 50-day simple moving average is 1.32 while VRCA share price is 1.11, making it a Sell technically.
- VRCA stock price is 1.11 and Verrica Pharmaceuticals 200-day simple moving average is 4.97, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
40
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Sell
The current Verrica Pharmaceuticals [VRCA] share price is $1.11. The Score for VRCA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
100.53M
Price in USD:
1.11
Share Volume:
1.33M
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.70
Sell
40
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 1.11 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 1.11 while VRCA 8-day exponential moving average is 0.99, which is a Buy signal.
- The stock price of VRCA is 1.11 while Verrica Pharmaceuticals 20-day EMA is 1.05, which makes it a Buy.
- Verrica Pharmaceuticals 50-day exponential moving average is 1.58 while VRCA share price is 1.11, making it a Sell technically.
- VRCA stock price is 1.11 and Verrica Pharmaceuticals 200-day simple moving average is 3.93, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Verrica Pharmaceuticals is a Sell
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 48.94, which suggest Verrica Pharmaceuticals is oversold
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (0.8 - 1.44), which suggest Verrica Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (0.62 - 5.5), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.